Racial and Sociodemographic Disparities in Hepatitis C Treatment at an Urban Academic Medical Center, 2018-2023 [0.03%]
2018-2023年城市学术医学中心丙肝治疗中的种族和社会人口统计差异
Ahmed D Elnaiem,Anand B Chukka,Cynthia M So-Armah et al.
Ahmed D Elnaiem et al.
Background: Hepatitis C virus (HCV) disproportionately affects racial minorities and socially disadvantaged groups in the United States. Despite highly effective direct-acting antiviral (DAA) therapies, treatment disparit...
A pre-post study of the impact of a multidisciplinary model of care on linkage to hepatitis C care following release from prison: The Beyond Prison Walls study [0.03%]
一项多学科护理模式对监狱释放人员接受丙肝治疗影响的前后对照研究：超越监狱高墙研究
Nadine Kronfli,Andrea Mambro,Allen O&#x;Brien et al.
Nadine Kronfli et al.
Background: Many people are released from prison with untreated hepatitis C virus (HCV) and fail to link to care due to competing priorities. We compared linkage to HCV care among individuals who engaged in a multidiscipl...
Jordan Hindson
Jordan Hindson
Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study [0.03%]
HBV再活化在HCV治疗患者的HBV/HCV合并感染中的危险因素：一项单中心研究
Young Joo Park,Ki Youn Yi,Hyun Young Woo et al.
Young Joo Park et al.
Hepatitis B virus (HBV) reactivation in patients with HBV/hepatitis C virus (HCV) co-infection due to direct-acting antiviral agent (DAA) therapy is a growing concern. This study focused on 47 patients with chronic hepatitis C (CHC) and pos...
Utilizing Theory of Planned Behaviour to increase intention to participate in hepatitis C treatment therapy among Methadone maintenance therapy clients (MMT) in Malaysia: A cluster randomised control trial [0.03%]
马来西亚利用计划行为理论增加美沙酮维持治疗患者参与丙型肝炎治疗意愿：一项群组随机对照试验
Mohd Hafiidz Baharudin,Siti Aisah Mokhtar,Ahmad Zaid Fattah Azman et al.
Mohd Hafiidz Baharudin et al.
Introduction: The World Health Organization (WHO) has targeted eliminating viral hepatitis as a public health problem by 2030. Thus, high-risk groups such as Methadone Maintenance Therapy (MMT) clients should be targeted ...
Randomized Controlled Trial
PloS one. 2025 May 22;20(5):e0324718. DOI:10.1371/journal.pone.0324718 2025
Evaluating the effectiveness of a population-level health intervention to increment HCV treatment coverage in tuscany region, Italy: An interrupted time series analysis [0.03%]
一项针对意大利托斯卡纳地区的群体肝炎C病毒治疗干预措施的效果评估：中断时间序列分析方法
Chiara Seghieri,Luca Ceccarelli,Costanza Tortù et al.
Chiara Seghieri et al.
Worldwide, an estimated 57.8 million people are chronically infected with the Hepatitis C virus (HCV). The advent of direct-acting antivirals (DAAs) has made possible the definition of elimination targets by 2030. This study aimed to evalua...
Hannah Roth,Andrew Aronsohn
Hannah Roth
TeleHCV: A single-visit protocol and minimal passive remote monitoring are sufficient to achieve high SVR with a sofosbuvir-velpatasvir regimen [0.03%]
远程单次随访联合最少的被动性远程监测对索磷布韦维帕他韦治疗患者疗效影响的研究： TeleHCV研究
Jerônimo De Conto Oliveira,Fernando Comunello Schacher,Marisa Boff Costa et al.
Jerônimo De Conto Oliveira et al.
Aim: Chronic Hepatitis-C Virus (HCV) treatment has evolved significantly in recent years with Direct-Acting Antivirals (DAAs). The traditional care cascade includes several steps that limit its impact, and simplification ...
Health economic outcomes of a minimal monitoring approach to providing HCV therapy [0.03%]
HCV治疗的最小化监测方案的成本效益分析
Benjamin P Linas,Michelle Weitz,Tannishtha Pramanick et al.
Benjamin P Linas et al.
Background: The ACTG A5360 trial demonstrated that HCV treatment without planned on-treatment monitoring is safe and effective. We report the health economic outcomes of MINMON. ...
More than 10 years of IFN-free HCV treatment and viral hepatitis elimination: Mission not completed! [0.03%]
无IFN丙肝治疗和病毒性肝炎消除超过十年：使命尚未完成！
Niklas Luhmann,Heiner Wedemeyer
Niklas Luhmann
耗时 0.19236 秒，为您在
48229835
条记录里面共找到 505 篇文章 [XML]